Aspen Neuroscience
Aspen Neuroscience develops autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS disorders.
Also Known As
Aspen Neurosciences
CFO
Legal Name
Aspen Neuroscience, Inc.
Company Operating Status
Active
Competitors
Country
Crunchbase URL
Facebook URL
Former CEO
Founded Date
2018
Founder
Funding Round Date
May 9, 2022
Funding Round Amount (USD)
147,500,000
Funding Type
Latest Funding Round Date
November 20, 2025
Latest Funding Round Amount (USD)
115,000,000
Latest Funding Type
LinkedIn URL
Location
Number of Employees (Ranges)
51 – 200
Phone Number
+18582631222
Pitchbook URL
Total Funding Amount (USD)
339,000,000
Twitter URL
Official Website
Find more companies like Aspen Neuroscience
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.